Skip to main content
XOMA Royalty Corp logo

XOMA Royalty Corp — Investor Relations & Filings

Ticker · XOMA ISIN · US98419J3059 US Financial and insurance activities
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2025-10-03 Capital/Financing Update
Country US United States of America
Listing US XOMA

About XOMA Royalty Corp

https://xoma.com/

XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to potential future milestone and royalty payments. The company's portfolio consists of assets associated with pre-commercial clinical candidates being developed by various pharmaceutical and biotech partners. In exchange for these economic rights, XOMA provides its partners with non-dilutive, non-recourse capital to fund their internal drug development programs. This portfolio-based strategy, encompassing over 120 assets, is designed to diversify risk away from single-asset clinical outcomes. XOMA focuses on managing these royalty assets rather than direct drug development.

Recent filings

Filing Released Lang Actions
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details an 'at the market' offering of common stock with a sales agreement involving a sales agent, Leerink Partners. The document includes information about the offering size, plan of distribution, use of proceeds, risk factors, and company overview. It is a capital raising document describing the terms and conditions of a stock offering, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full prospectus supplement, not just an announcement or notice. Hence, the classification is CAP with high confidence.
2025-10-03 English
SC TO-T/A Filing
M&A Activity Classification · 100% confidence The document is a Schedule TO filing, which is a Tender Offer Statement under the Securities Exchange Act of 1934. It is an amendment (No. 3) to a tender offer statement related to a third-party tender offer by XOMA Royalty Corporation to purchase shares of LAVA Therapeutics N.V. The document includes details about the extension of the offer, references to the Offer to Purchase, Share Purchase Agreement, and related exhibits. This type of filing is specifically related to merger and acquisition activity, particularly tender offers. It is not a full annual or quarterly report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. The document is clearly about a takeover bid and related tender offer disclosures, which fits the M&A Activity category (Code: TAR). The document length is sufficient and contains substantive information about the tender offer amendment, not just an announcement or certification. Therefore, the correct classification is M&A Activity (TAR) with high confidence.
2025-10-02 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content describes a Certificate of Correction to a previously filed Certificate of Designation related to preferred stock, correcting a typographical error. There are no financial statements or detailed financial data included, nor is this a full annual or quarterly report. The document is short (3935 characters) and primarily serves as a regulatory announcement of a corporate amendment. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about the correction. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-09-26 English
PRIMARY DOCUMENT
Director's Dealing
2025-09-23 English
PRIMARY DOCUMENT
Director's Dealing
2025-09-23 English
PRIMARY DOCUMENT
Director's Dealing
2025-09-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.